For example, a cleaved product of cystatin C, an inhibitor of cysteine proteases has been reported as a potential biomarker in the cerebrospinal fluid of multiple sclerosis patients [30], although the validity of this peptide as disease biomarker has recently been challenged by another study [31]. The gene discussed is CTSB; the disease is multiple sclerosis.